Breast Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are 18 years of age or older.
- People who have been diagnosed with breast cancer confirmed through a laboratory or tissue test.
- People whose breast cancer is locally advanced (meaning the cancer has grown larger or spread to nearby tissue or lymph nodes, but has not spread to distant parts of the body).
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are under 18 years of age.
- People whose cancer has spread to distant parts of the body (such as other organs or bones).
- People who have been diagnosed with a second, separate type of cancer.
- People who are not considered suitable candidates for chemotherapy treatment.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.
Primary endpoints
The response to neoadjuvant chemotherapy in locally advanced breast cancer in relation to CD10 expression
Can't join this trial?
Data last synced from ClinicalTrials.gov: 31 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.